In 2025, Bruna Bombassaro and team from the University of Campinas reviewed how dietary factors like caffeine, capsaicin, cinnamon, curcumin, resveratrol, and fatty acids (EPA, DHA, oleic acid) activate brown and beige adipose tissues (BAT) to burn calories via thermogenesis.

In 2025, Yunxiang Sun and team from Johns Hopkins and Brazilian universities analyzed survey data from over 87,000 adults in Brazil. They used self-reports on diabetes, depression, and diet (via food frequency questionnaires) to check how ultra-processed food (UPF) intake affects the depression-diabetes connection, running stats adjusted for age, income, and more.

In 2025, a study from AnnalsofIM and others tracked 50,000+ adults with diabetes over years, using health records to compare exercise habits. They grouped people as inactive, insufficiently active, weekend warriors (≥150 min/week in 1–2 sessions), or regularly active, measuring heart-related deaths and overall mortality.

In 2025, Haohao Zhang and team at Zhengzhou University compared three diets for 52 obese people with type 2 diabetes: intermittent fasting (5:2 plan, eating normally five days and cutting calories two), time-restricted eating, and steady calorie reduction. They measured weight, blood sugar, and insulin response over months.

This statement by Dr. Gabrielle Lyon isn’t just catchy—it’s scientifically sound. A 2024 Scientific Reports study analyzing nearly 11,000 adults found that a high lean mass to visceral fat ratio was tied to up to 88% lower risk of type 2 diabetes and significantly fewer cases of high blood pressure and abnormal cholesterol levels.

Globally, added sugar now makes up around 10% of total calories consumed, ranking just behind grains and produce. But while those provide some nourishment, sugar contributes little and harms much. A 2023 Annual Review study warns that sugar—not fat—is driving the chronic disease epidemic. And sugar-sweetened beverages (SSBs) are the worst offenders.

A 2025 review in Nutrients by Zhang dives into the crucial roles selenium plays in our bodies. As a key part of selenoproteins, this micronutrient helps balance redox reactions, regulate cell growth, support the immune system, and guard against DNA damage, chronic inflammation, insulin resistance, and neurodegeneration.

A 2025 double-blind, placebo-controlled trial by Lamichhane et al. in Nutrients found that elderly prediabetic adults taking 80 mg/day of curcumin for 12 weeks saw significant reductions in HbA1c, a key marker of long-term blood sugar control.

A 2025 pilot study from the University of Naples “Federico II” found that the diabetes drug liraglutide (a GLP-1 receptor agonist) reduced monthly migraine days by over 50% in patients with chronic migraine.